COVID-19 remained deadlier than influenza this past season, although the difference in mortality shrunk compared with past years, according to a study comparing outcomes of patients hospitalized with the illnesses. “In...
With the risk of mosquito-borne disease expected to grow with climate change, a new study by Stanford researchers and their Kenyan colleagues sheds light on the factors that put communities at risk for these illnesses –...
Adjuvants—ingredients that help boost the immune response in vaccines—have been used in vaccines for decades. But inducing a stronger immune response can result in more unwanted side effects, like swelling at the...
The saliva of mosquitoes infected with dengue viruses contains a substance that thwarts the human immune system and makes it easier for people to become infected with the potentially deadly viruses, new research reveals...
Researchers from TU/e, Fontys Hogescholen and Rijnstate Ziekenhuis have developed a new bioluminescence-based sensor that can detect tiny amounts of viral or bacterial DNA/RNA in samples. PCR testing – the highly...
Infectious diseases are a problem everywhere — but more so in the world’s poorer countries. Every year, malaria, HIV and tuberculosis (TB) kill over 2.8 million people, and more than 1.7 billion people require treatment...
In a trial led by Stanford Medicine researchers, more than half of patients with persistent smell loss saw improvement with injections of platelet-rich plasma. Early in the pandemic, when people with COVID-19 began...
Time heals many wounds. But not all of them. Three years ago, on March 11, 2020, the World Health Organization officially bestowed pandemic status on COVID-19. Now, much of the fear that accompanied that declaration has...
A recent study found that chatbot systems that used artificial intelligence (AI) could be valuable in providing access to current, accurate, and complete information about infectious diseases and vaccines against them...
The magnitude and quality of a key immune cell’s response to vaccination with two doses of the Pfizer-BioNTech COVID-19 vaccine were considerably lower in people with prior SARS-CoV-2 infection compared to people...